Suven Pharmaceuticals Q3 Results
- BSE: 543064
- NSE: SUVENPHAR
- ISIN: INE03QK01018
- Sector: Biotechnology & Drugs
BSE
1,169.45
36.40 (3.21%)
36.40 (3.21%)Volume9.36 K
Updated: Wed 19 Mar, 2025 | 15:29:08
NSE
1,167.7534.00 (3.00%)
34.00 (3.00%)Volume4.79 L
Updated: Wed 19 Mar, 2025 | 15:29:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹307.15 Cr.(39.73%)
- Operating Profit₹97.35 Cr.(85.81%)
- Profit After Tax₹82.88 Cr.(77.27%)
- Operating Margin31.69%(32.98%)
Note: Comparison is on YoY basis
Quarterly - Suven Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 23 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 307.15 | 231.05 | 19.18% | 219.82 | 39.73% |
| Selling/ General/ Admin Expenses Total | 63.29 | 28.58 | 22.02% | 32.83 | 92.77% |
| Depreciation/ Amortization | 20.35 | 11.89 | 19.99% | 12.75 | 59.59% |
| Other Operating Expenses Total | 70.53 | 13.16 | 41.68% | 14.42 | 389.16% |
| Total Operating Expense | 209.80 | 144.98 | 22.93% | 167.43 | 25.31% |
| Operating Income | 97.35 | 86.07 | 11.83% | 52.39 | 85.81% |
| Net Income Before Taxes | 109.73 | 105.41 | 10.28% | 65.47 | 67.61% |
| Net Income | 82.88 | 79.56 | 0.81% | 46.75 | 77.27% |
| Diluted Normalized EPS | 3.23 | 3.13 | 0.62% | 1.84 | 75.54% |